Croucher, P., Shipman, C., Lippitt, J., Perry, M., Asosingh, K., Hijzen, A., . . . Vanderkerken, K. (2001). Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Citación estilo ChicagoCroucher, P., et al. Osteoprotegerin Inhibits the Development of Osteolytic Bone Disease in Multiple Myeloma. 2001.
Cita MLACroucher, P., et al. Osteoprotegerin Inhibits the Development of Osteolytic Bone Disease in Multiple Myeloma. 2001.
Warning: These citations may not always be 100% accurate.